Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
Chicago-referens (17:e uppl.)Shehab, Habibul Mohsin, och Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
MLA-referens (8:e uppl.)Shehab, Habibul Mohsin, och Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.